Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer
NCT07527143 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 25
Last updated 2026-04-14
Summary
This study evaluates how women feel about using DNA from a vaginal fluid collection for early detection of endometrial cancer.
Conditions
- Endometrial Carcinoma
Interventions
- OTHER
-
Non-Interventional Study
Non-interventional study
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Shariska Harrington, MD · Mayo Clinic in Rochester
Eligibility
- Min Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-04-06
- Primary Completion
- 2027-04-06
- Completion
- 2027-04-06
Countries
- United States
Study Locations
More Related Trials
-
DNA Methylation for Screening Uterine Cervical Lesions
NCT03960879 ·Status: UNKNOWN
-
Vaginal Fluid Collection for Detection of Endometrial Cancer
NCT06294886 ·Status: RECRUITING
-
DNA Methylation Testing for the Screening of Uterine Cervical Lesion
NCT04646954 ·Status: UNKNOWN ·Phase: PHASE3
-
Cell-free DNA Methylation for Endometrial Cancer
NCT04651738 ·Status: UNKNOWN ·Phase: NA
-
Cytologic Analysis of Distention Media as a Screening Test for Endometrial Cancer
NCT00462969 ·Status: COMPLETED ·Phase: NA
-
Assessment of Prognosis Using Peripheral Blood Circulating Tumor DNA in Patients With Cervical Cancer
NCT05602831 ·Status: UNKNOWN
-
DNA Methylation for Screening Uterine Cervical Lesions: A Case-control Study
NCT03961191 ·Status: UNKNOWN
-
Assessment of Screening Modalities for Gynecologic Cancers
NCT00879840 ·Status: COMPLETED
-
Detection of Endometrial Cancer Through Risk Modelling
NCT06268626 ·Status: RECRUITING
-
Cervical Cytology DNA Methylation for Endometrial Lesion Screening and Follow-up
NCT07298707 ·Status: NOT_YET_RECRUITING
-
Assessing Uterine Cancer Risk in Lynch Syndrome Carriers Using Vaginal Self-sampling and a Health Questionnaire
NCT07194551 ·Status: RECRUITING ·Phase: NA
-
DNA Methylation Biomarkers for Cervical Cancer Screening
NCT02605941 ·Status: UNKNOWN
-
Host DNA Methylation for Endometrial Cancer Screening
NCT05290415 ·Status: UNKNOWN
-
Clinical Studies of Endometrial Cytology and Cervical Methylation Assays in Endometrial Cancer Screening and Fertility-Preservation Evaluation
NCT06672341 ·Status: NOT_YET_RECRUITING
-
Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer
NCT04574635 ·Status: ACTIVE_NOT_RECRUITING
-
Application of Plasma Circulating HPV DNA Testing to Management of Cervical Intraepithelial Neoplasia
NCT04274465 ·Status: COMPLETED
-
The Clinical Utility of DNA Methylation Testing in Patient-collected Urine and Vaginal Samples to Detect Endometrial Cancer: a Case-control Study
NCT06846775 ·Status: RECRUITING
-
The Exploration of Personalized ctDNA Based MRD in the Clinical Significance of Cervical Cancer
NCT06283875 ·Status: NOT_YET_RECRUITING
-
Cervical Cancer Screening Project Part C
NCT01575444 ·Status: TERMINATED
-
DNA Cytometry for Cervical Cancer Screening in China
NCT00902551 ·Status: COMPLETED
-
DNA CDO1 and CELF4 Methylation for Endometrial Cancer Screening
NCT05290922 ·Status: UNKNOWN
-
Collecting Tumor Samples From Patients With Gynecological Tumors
NCT00897442 ·Status: COMPLETED
-
DNA Methylation and the Increased Risk of Cervical Cancer Development
NCT06859151 ·Status: NOT_YET_RECRUITING
-
Role of Mitochondrial Bioenergetics in Resilience for Gynecologic Cancer
NCT07046936 ·Status: SUSPENDED
-
Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer
NCT07480902 ·Status: RECRUITING ·Phase: NA